Physician profile
Barry S Auerbach
NPI 1841388360
$2,230.18
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $186 · 2020: $387 · 2021: $425 · 2022: $539 · 2023: $693.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $688 · Education: $5.17.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $688.28 |
| Education | $5.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $495.22 | 2022-2023 | Azstarys |
| Supernus Pharmaceuticals, INC. | $311.28 | 2021-2023 | Qelbree |
| Takeda Pharmaceuticals U.S.A., INC. | $263.30 | 2020-2021 | |
| Ironshore Pharmaceuticals INC. | $199.26 | 2019-2023 | Jornay Pm |
| Cranial Technologies, INC | $136.63 | 2019-2023 | Doc Band |
| Merck Sharp & Dohme LLC | $132.56 | 2020-2023 | Gardasil 9, Vaxelis, Vaxneuvance |
| Tris Pharma INC | $129.62 | 2020-2021 | |
| Neos Therapeutics, LP | $98.86 | 2022-2023 | Adzenys Xr-Odt |
| Kaleo, INC. | $75.71 | 2020-2022 | |
| Sanofi Pasteur INC. | $65.07 | 2020-2023 | |
| Alk-Abello, INC | $37.65 | 2023 | Grastek, Odactra, Ragwitek |
| Sobi, INC | $36.86 | 2019-2020 | |
| Pfizer INC. | $34.80 | 2020-2022 | |
| Shire North American Group INC | $28.51 | 2019 | |
| Seqirus USA INC | $26.24 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phadia US INC. | $25.67 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $23.51 | 2023 | Flumist Quadrivalent |
| Novartis Pharmaceuticals Corporation | $21.35 | 2019 | |
| Vertical Pharmaceuticals, LLC | $19.85 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $17.58 | 2021 | |
| Dermira, INC. | $14.28 | 2020 | |
| Adlon Therapeutics L.P. | $12.24 | 2021 | |
| Jazz Pharmaceuticals INC. | $12.07 | 2020 | |
| Genentech USA, INC. | $12.06 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barry Auerbach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.